Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Thrombomodulin functions as a plasminogen receptor to modulate angiogenesis.

Chen PK, Chang BI, Kuo CH, Chen PS, Cho CF, Chang CF, Shi GY, Wu HL.

FASEB J. 2013 Nov;27(11):4520-31. doi: 10.1096/fj.13-227561. Epub 2013 Aug 13.

PMID:
23943648
[PubMed - indexed for MEDLINE]
2.

Human plasminogen kringle 1-5 inhibits angiogenesis and induces thrombomodulin degradation in a protein kinase A-dependent manner.

Cho CF, Chen PK, Chang PC, Wu HL, Shi GY.

J Mol Cell Cardiol. 2013 Oct;63:79-88. doi: 10.1016/j.yjmcc.2013.07.009. Epub 2013 Jul 21.

PMID:
23880609
[PubMed - indexed for MEDLINE]
3.

Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation.

Tarui T, Akakura N, Majumdar M, Andronicos N, Takagi J, Mazar AP, Bdeir K, Kuo A, Yarovoi SV, Cines DB, Takada Y.

Thromb Haemost. 2006 Mar;95(3):524-34.

PMID:
16525582
[PubMed - indexed for MEDLINE]
4.

Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor.

Ellis V, Behrendt N, Danø K.

J Biol Chem. 1991 Jul 5;266(19):12752-8.

PMID:
1829461
[PubMed - indexed for MEDLINE]
Free Article
5.

Integrin alphaMbeta2 orchestrates and accelerates plasminogen activation and fibrinolysis by neutrophils.

Pluskota E, Soloviev DA, Bdeir K, Cines DB, Plow EF.

J Biol Chem. 2004 Apr 23;279(17):18063-72. Epub 2004 Feb 9.

PMID:
14769799
[PubMed - indexed for MEDLINE]
Free Article
6.

Inactivation of receptor-bound pro-urokinase-type plasminogen activator (pro-uPA) by thrombin and thrombin/thrombomodulin complex.

Wilhelm S, Wilhelm O, Schmitt M, Graeff H.

Biol Chem Hoppe Seyler. 1994 Sep;375(9):603-8.

PMID:
7840902
[PubMed - indexed for MEDLINE]
7.

Pericellular proteolysis by leukocytes and tumor cells on substrates: focal activation and the role of urokinase-type plasminogen activator.

Kindzelskii AL, Amhad I, Keller D, Zhou MJ, Haugland RP, Garni-Wagner BA, Gyetko MR, Todd RF 3rd, Petty HR.

Histochem Cell Biol. 2004 Apr;121(4):299-310. Epub 2004 Mar 20.

PMID:
15042374
[PubMed - indexed for MEDLINE]
8.

The recombinant lectin-like domain of thrombomodulin inhibits angiogenesis through interaction with Lewis Y antigen.

Kuo CH, Chen PK, Chang BI, Sung MC, Shi CS, Lee JS, Chang CF, Shi GY, Wu HL.

Blood. 2012 Feb 2;119(5):1302-13. doi: 10.1182/blood-2011-08-376038. Epub 2011 Nov 18.

PMID:
22101897
[PubMed - indexed for MEDLINE]
Free Article
10.

High urokinase expression contributes to the angiogenic properties of endothelial cells derived from circulating progenitors.

Basire A, Sabatier F, Ravet S, Lamy E, Mialhe A, Zabouo G, Paul P, Gurewich V, Sampol J, Dignat-George F.

Thromb Haemost. 2006 Apr;95(4):678-88.

PMID:
16601839
[PubMed - indexed for MEDLINE]
11.

Plasminogen mediates the atherogenic effects of macrophage-expressed urokinase and accelerates atherosclerosis in apoE-knockout mice.

Kremen M, Krishnan R, Emery I, Hu JH, Slezicki KI, Wu A, Qian K, Du L, Plawman A, Stempien-Otero A, Dichek DA.

Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17109-14. doi: 10.1073/pnas.0808650105. Epub 2008 Oct 28.

PMID:
18957535
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Anti-angiogenic activity of the recombinant kringle domain of urokinase and its specific entry into endothelial cells.

Kim KS, Hong YK, Joe YA, Lee Y, Shin JY, Park HE, Lee IH, Lee SY, Kang DK, Chang SI, Chung SI.

J Biol Chem. 2003 Mar 28;278(13):11449-56. Epub 2003 Jan 15.

PMID:
12529357
[PubMed - indexed for MEDLINE]
Free Article
13.

The role of plasminogen in angiogenesis in vivo.

Oh CW, Hoover-Plow J, Plow EF.

J Thromb Haemost. 2003 Aug;1(8):1683-7.

PMID:
12911578
[PubMed - indexed for MEDLINE]
14.

The receptor for urokinase-type plasminogen activator of a human keratinocyte line (HaCaT).

Reinartz J, Link J, Todd RF, Kramer MD.

Exp Cell Res. 1994 Oct;214(2):486-98.

PMID:
7925643
[PubMed - indexed for MEDLINE]
15.

Cell-surface plasminogen activation causes a retraction of in vitro cultured human umbilical vein endothelial cell monolayer.

Conforti G, Dominguez-Jimenez C, Rønne E, Høyer-Hansen G, Dejana E.

Blood. 1994 Feb 15;83(4):994-1005.

PMID:
8111067
[PubMed - indexed for MEDLINE]
Free Article
16.

Regulation of urokinase receptor function and pericellular proteolysis by the integrin alpha(5)beta(1).

Bass R, Ellis V.

Thromb Haemost. 2009 May;101(5):954-62.

PMID:
19404550
[PubMed - indexed for MEDLINE]
17.

VEGF-initiated angiogenesis and the uPA/uPAR system.

Breuss JM, Uhrin P.

Cell Adh Migr. 2012 Nov-Dec;6(6):535-615. doi: 10.4161/cam.22243. Epub 2012 Oct 17. Review.

PMID:
23076133
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin.

Biliran H Jr, Sheng S.

Cancer Res. 2001 Dec 15;61(24):8676-82.

PMID:
11751384
[PubMed - indexed for MEDLINE]
Free Article
19.

Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.

Vines DJ, Lee SW, Dichek DA, Ellis V.

J Pept Sci. 2000 Sep;6(9):432-9.

PMID:
11016879
[PubMed - indexed for MEDLINE]
20.

Urokinase induces receptor mediated brain tumor cell migration and invasion.

MacDonald TJ, DeClerck YA, Laug WE.

J Neurooncol. 1998 Dec;40(3):215-26.

PMID:
10066093
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk